Dr. Sherman Chang will now serve as Senior Director of Research & Development, and will be in charge of the company’s clinical data capture, warehousing, and analytics that is the foundation of Proove’s products, research and development efforts. Dr. Chang has an extensive background working with early stage biotechnology companies in southern California. Most recently, he was the Senior Director of R&D at DermTech International and developed a cancer biomarker to detect melanoma non-invasively. Previously, he was at Verenium and Torrey Mesa Research Institute. He has a Ph.D. In Molecular Biology and he completed post-doctoral work at UCSD and The Salk Institute.
“I am very excited to help explore the vast clinical data the company has collected over the last several years, which I view as a gold mine waiting to be discovered,”
John Hubbard has been promoted from Clinical Science Liaison to Senior Director of Clinical Services and Account Management. As Senior Director of Clinical Services and Account Management, John will oversee Proove’s growing team of Clinical Science Liaisons, who are responsible for effectively administering testing and capturing key patient data at client sites. John will also be managing client operations, ensuring Proove Bio is surpassing expectations, and delivering value to physicians, providers, and patients.
“First of all I feel honored to be part of such an incredible team here at Proove Biosciences. To be recognized by my peers means a great deal to me. The mission to improve the lives of patients and to assist the physicians responsible for their care decisions is what drives us each day. I am proud to be one of the change agents here at Proove,” stated Hubbard.
Mehrdad Zoleikhaeian has been promoted to the position of Vice President of Laboratory Operations. Mehrdad has 15 years of experience in molecular genetic testing. He has worked as a laboratory scientist for Quest, LabCorp, Response Genetics, and UCI. He completed his initial training at UCLA and he is a State of California Clinical Genetic Molecular Biologist Scientist (CGMBS). Mehrdad has helped guide the set-up and validation of company assays, and developed gene sequencing assays for the Company.
“Personalized medicine has become a reality today, our goal is to make it accessible to everyone so that patients benefit from increased comfort, shorter recovery time, and cost effective treatment,” stated Zoleikhaeian.
“Sherman, John, and Mehrdad have played a critical role in Proove Biosciences’